Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-2-18
|
pubmed:abstractText |
Preliminary studies have demonstrated that some pituitary adenomas secrete immunoreactive interleukin-6 (irIL-6) when cultured in vitro. We have extended these studies by investigating 100 pituitary adenomas of different types measuring immunoreactive and bioactive IL-6. Tumors were cultured either as explants without fetal calf serum or as dispersed cells with 10% total calf serum. Fifty-three of the 100 (53%) pituitary cultures were found to release irIL-6 and in 44 adenomas examined, 32 (72.7%) secreted bioactive IL-6. In 61 explant cultures, 30 adenomas released IL-6, indicating autonomous secretion. The amount of IL-6 released by adenomas in cell culture was generally higher, although the incidence was similar to explant cultures. IrIL-6 was released by 7 of 14 prolactinomas, 15 of 27 somatotrophinomas, 5 of 7 corticotrophinomas (including 2 Nelson's adenomas), 1 of 1 thyrotrophinomas, 2 of 2 gonadotrophinomas, and 23 of 49 clinically non-functioning adenomas. Periadenomatous tissue removed from a patient with a corticotrophinoma was found to secrete IL-6 but in much lower concentration than from the adenoma tissue. Tumor necrosis factor-alpha and -gamma-interferon were not detected in the conditioned media. Four IL-6-secreting adenomas were examined by in situ hybridization for IL-6 messenger RNA, and three of these were positive with fluorescence present throughout the tissue examined. We have provided evidence that over half of pituitary adenomas secrete IL-6 which is bioactive and that IL-6 is synthesized within the tumor by the adenoma cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
180-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8288702-Adenoma,
pubmed-meshheading:8288702-Adolescent,
pubmed-meshheading:8288702-Adult,
pubmed-meshheading:8288702-Aged,
pubmed-meshheading:8288702-Culture Media,
pubmed-meshheading:8288702-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8288702-Female,
pubmed-meshheading:8288702-Humans,
pubmed-meshheading:8288702-In Situ Hybridization,
pubmed-meshheading:8288702-Interleukin-6,
pubmed-meshheading:8288702-Male,
pubmed-meshheading:8288702-Middle Aged,
pubmed-meshheading:8288702-Pituitary Neoplasms,
pubmed-meshheading:8288702-RNA, Messenger
|
pubmed:year |
1994
|
pubmed:articleTitle |
Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas.
|
pubmed:affiliation |
University Department of Medicine, Northern General Hospital, Sheffield, England.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|